Create Account | Sign In: Author or Forum

Search Symptoms

Category: Cardiology | Family Medicine | Geriatrics | Infections | Internal Medicine | Pharmacy | Journal

Back to Journal Articles

Statins May Be Tied to Lower Risk for COVID-19 Death

Last Updated: October 25, 2021.

MONDAY, Oct. 25, 2021 (HealthDay News) -- Preexisting statin treatment is associated with slightly lower COVID-19 mortality, according to a study published online Oct. 14 in PLOS Medicine.

Rita Bergqvist, from the Karolinska Institutet in Stockholm, and colleagues assessed the relationship between statin treatment initiated before the pandemic and COVID-19 mortality among 963,876 Stockholm residents (ages 45 years or older).

The researchers reported that 17.6 percent of the patients in the cohort were statin users. COVID-19-related deaths occurred in 0.5 percent of the statin users and 0.2 percent of nonusers. In an adjusted analysis, statin treatment was associated with lowered COVID-19 mortality (adjusted hazard ratio, 0.88). This association remained consistent across age groups, sexes, and COVID-19 risk groups.

"Our findings support the continued use of statins for conditions such as cardiovascular disease and high levels of blood lipids in line with current recommendations during the COVID-19 pandemic," a coauthor said in a statement.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text


Previous: More Than Half of U.S. Infants Born in High-Volume Obstetric Hospitals Next: Suicide Risk Up for Long-Term Survivors of Childhood Cancer

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: